Dr. Sunandana Chandra
Claim this profileNorthwestern University
Area of expertise
Melanoma
Sunandana Chandra has run 16 trials for Melanoma. Some of their research focus areas include:
Skin Cancer
Sunandana Chandra has run 16 trials for Skin Cancer. Some of their research focus areas include:
Affiliated Hospitals
Northwestern University
Northwestern Medicine Lake Forest Hospital
Clinical Trials Sunandana Chandra is currently running
Immunotherapy + Prednisone + Sirolimus
for Skin Cancer
This phase II trial tests the combination of nivolumab and ipilimumab with sirolimus and prednisone for the treatment of skin (cutaneous) cancer that cannot be removed by surgery (unresectable) or that has spread from where it first started to other places in the body (metastatic) in kidney transplant recipients. Immunotherapy with nivolumab and ipilimumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Sirolimus and prednisone are immunosuppressants that are given to keep the body from rejecting the transplanted kidney. Giving nivolumab and ipilimumab in combination with sirolimus and prednisone may kill more cancer cells, while also keeping the transplanted kidney healthy, in patients with unresectable or metastatic cutaneous cancer who have received a kidney transplant.
Recruiting
1 award
Phase 1 & 2
10 criteria
Nivolumab + Cabozantinib
for Melanoma
This trial tests if nivolumab and cabozantinib can help patients with mucosal melanoma. Nivolumab boosts the immune system, while cabozantinib stops cancer cells from growing. The goal is to prevent the cancer from coming back or spreading. Nivolumab and cabozantinib have shown efficacy in treating various cancers, including melanoma and renal cell carcinoma.
Recruiting
0 awards
Phase 2
More about Sunandana Chandra
Clinical Trial Related
3 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Sunandana Chandra has experience with
- Nivolumab
- Ipilimumab
- Pembrolizumab
- Avelumab
- Dabrafenib Mesylate
- Trametinib Dimethyl Sulfoxide
Breakdown of trials Sunandana Chandra has run
Melanoma
Skin Cancer
Cutaneous Melanoma
Merkel Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sunandana Chandra specialize in?
Sunandana Chandra focuses on Melanoma and Skin Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are BRAF positive.
Is Sunandana Chandra currently recruiting for clinical trials?
Yes, Sunandana Chandra is currently recruiting for 5 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Sunandana Chandra has studied deeply?
Yes, Sunandana Chandra has studied treatments such as Nivolumab, Ipilimumab, Pembrolizumab.
What is the best way to schedule an appointment with Sunandana Chandra?
Apply for one of the trials that Sunandana Chandra is conducting.
What is the office address of Sunandana Chandra?
The office of Sunandana Chandra is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.